Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids
dc.contributor.author | Vats, K. | |
dc.contributor.author | Das, T. | |
dc.contributor.author | Sarma, H. D. | |
dc.contributor.author | Banerjee, S. | |
dc.contributor.author | Pillai, M. R. A. | |
dc.date.accessioned | 2014-04-16T09:45:18Z | |
dc.date.available | 2014-04-16T09:45:18Z | |
dc.date.issued | 2013 | |
dc.description.division | RPhD;RB&HSD | en |
dc.format.extent | 5705 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Cancer Biotherapy & Radiopharmaceuticals, 2013. Vol. 28 (10): pp. 737-745 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/9115 | |
dc.language.iso | en | en |
dc.subject | bone pain palliation | en |
dc.subject | radiolabeled phosphonic acid | en |
dc.subject | Thulium-170 | en |
dc.title | Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids | en |
dc.type | Article | en |